| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CRMD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | - | - | |
| COO | 270.5K | $2.24M | - | |
| Other | 260.7K | $2.16M | - | |
| Dir | 231.5K | - | - | |
| Other | 133.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 60,000 | $2.68 | $160,966.00 | -100% | |
| Sep 22, 2015 | Dillione Janet63 | Director | Buy | 15,000 | $2.66 | $39,900.00 | New | |
| Jun 30, 2015 | Milby Randy | Chief Executive Officer | Buy | 1,610 | $3.88 | $6,246.80 | +2.9% | |
| Jun 23, 2015 | Markvicka Taunia | Director | Buy | 4,000 | $4.81 | $19,240.00 | New | |
| Jun 15, 2015 | Milby Randy | Chief Executive Officer | Buy | 1,245 | $5.02 | $6,249.90 | +2.3% | |
| Jun 4, 2015 | Duffy Matthew | Director | Sale+OE | 30,000 | $6.48 | $194,412.00 | -36.0% | |
| Jun 1, 2015 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 30,000 | $6.37 | $191,052.00 | -100% | |
| Jun 1, 2015 | Lefkowitz Steven W | Director | Sell | 39,072 | $6.53 | $255,099.42 | -25.0% | |
| May 29, 2015 | Milby Randy | Chief Executive Officer | Buy | 1,026 | $6.09 | $6,248.34 | +1.9% | |
| May 15, 2015 | Milby Randy | Chief Executive Officer | Buy | 979 | $6.38 | $6,246.02 | +1.9% |